Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease.
about
Hematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsGene therapy on the moveErythroid promoter confines FGF2 expression to the marrow after hematopoietic stem cell gene therapy and leads to enhanced endosteal bone formation.Release of human cytomegalovirus from latency by a KAP1/TRIM28 phosphorylation switchClinical applications of gene therapy for primary immunodeficiencies.Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.Gene therapy: too much splice can spoil the dish.Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.A KRAB/KAP1-miRNA cascade regulates erythropoiesis through stage-specific control of mitophagy.[A KRAB/KAP1-miRNA cascade regulates erythropoiesis through stage-specific control of mitophagy].Development of gene therapy for blood disorders: an update.Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospects.Lentiviral vectors for the treatment of primary immunodeficiencies.High Level of Perforin Expression Is Required for Effective Correction of Hemophagocytic Lymphohistiocytosis.Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice.Lentiviral Vector Gene Therapy Protects XCGD Mice From Acute Staphylococcus aureus Pneumonia and Inflammatory Response.Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy.CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application.Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.A New Chapter on Targeted Gene Insertion for X-CGD: Do Not Skip the Intro(n).
P2860
Q26859147-A682CC06-17E9-4E3B-8969-1BC8E9AA23F1Q27007012-95D8017F-A1CE-4C20-BBEC-2A6CFEABB513Q34281991-0EA5FB39-6A5D-4735-B043-72A8DAB90FC3Q35260579-B4098723-DEA7-4A12-97F7-E116ADFD0C30Q35539617-E372D8C3-8560-46B2-8388-E2800DA3263EQ35618854-CD4354EC-D3F8-4E9A-A1D2-826CCD0A352FQ35913759-6CA38A25-F204-4134-9A8C-C66EBC94E5FDQ36659242-55944151-4C27-4E0F-9E56-C7ACF398B908Q36917344-4107158C-B0B5-4437-8940-5FC165D223C6Q36972722-CC141DB0-6257-4270-8D7F-86CE21A1F255Q37132611-8F453998-1C04-4728-B142-C2F622D8A24FQ37265523-11AB1A60-8CD3-4F64-BF32-E602275FEB52Q38195200-421256B1-89EC-4CA0-A632-397DA7422491Q38754891-6DECCFF0-3B35-48BF-858E-42D3F983624FQ39042768-B0C0E25E-FA38-4A9F-BCB6-2A07C4777A1BQ39561887-51150967-552A-44D9-9AC0-FD94782398C2Q40183063-0F1EA66F-74D7-48BD-A936-2A6172571C1DQ40306400-7CAFD381-ED1C-4BD6-AA77-0B7C3DE5DB25Q42084870-61396268-7536-4A72-94C1-53702B5335E8Q45326104-9B9B4FC7-81A6-44D9-A045-A9B4E680B133Q50300216-BD7F2C85-1568-45EF-80DF-E26EF4EAE624
P2860
Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Lineage- and stage-restricted ...... chronic granulomatous disease.
@ast
Lineage- and stage-restricted ...... chronic granulomatous disease.
@en
Lineage- and stage-restricted ...... chronic granulomatous disease.
@nl
type
label
Lineage- and stage-restricted ...... chronic granulomatous disease.
@ast
Lineage- and stage-restricted ...... chronic granulomatous disease.
@en
Lineage- and stage-restricted ...... chronic granulomatous disease.
@nl
prefLabel
Lineage- and stage-restricted ...... chronic granulomatous disease.
@ast
Lineage- and stage-restricted ...... chronic granulomatous disease.
@en
Lineage- and stage-restricted ...... chronic granulomatous disease.
@nl
P2093
P2860
P356
P1433
P1476
Lineage- and stage-restricted ...... chronic granulomatous disease.
@en
P2093
A Viornery
M Wiznerowicz
P2860
P2888
P304
P356
10.1038/GT.2011.65
P577
2011-05-05T00:00:00Z
P5875
P6179
1011329501